Safety, Tolerability, and Efficacy of RLS103 in a Clinical Model of Photosensitive Epilepsy
Clinical trial NCT05678881 · TERMINATED
Trial details
- NCT number
- NCT05678881
- Sponsor
- Receptor Life Sciences
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-25
- Primary completion
- 2024-02-23
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.